BRD-K32847255-001-01-1 (Substance)

Compound:

3-[[2-Pyridin-2-Yl-6-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)pyrimidin-4-Yl]amino]propanoic Acid

Synonyms:BRD-K32847255-001-01-1

Id:340087502

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K32847255-001-01-1's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 LJP008 MCF10A 24H E11 GSK-J1 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP008 SKL.C 24H E11 GSK-J1 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP008 A549 24H E07 GSK-J1 10.00um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 LJP008 A549 24H E07 GSK-J1 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP008 HT29 24H E11 GSK-J1 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP008 PC3 24H E11 GSK-J1 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP008 SKL.C 24H E10 GSK-J1 0.37um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 LJP008 HEK293 24H E12 GSK-J1 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP008 SHSY5Y 24H E10 GSK-J1 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP008 HUVEC 24H E09 GSK-J1 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project